Originally developed for type 2 diabetes, semaglutide mimics a natural hormone to regulate blood sugar and appetite. As a GLP-1 receptor agonist, it slows digestion and signals fullness. Administered via weekly injection or daily pill, it benefits adults managing diabetes or seeking weight loss under medical supervision, often leading to significant, sustained reductions in body weight and A1C levels.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends